Cabinet Schertenleib is the only boutique firm in France that is 100% specialized in patent litigation.

Cabinet Schertenleib has been ranked in the top 6 patent litigation firms in France by Legal 500.

Cabinet Schertenleib is 'an effective niche patent litigation offering' with 'great technical understanding' of the technology and life sciences sectors.

Clients can rely on the 'responsive and technically gifted' Denis Schertenleib and Ombeline Degrèze-Péchade, who 'is skilled in regulatory law in the health sector'.

The group is currently representing biotech company Amgen in a patent infringement claim against Sanofi regarding hypercholesterolemia antibodies, and Mylan instructed Schertenleib to assist with a number of SPC revocation actions.

 

Legal500.png

 

 

 

 

 

Denis Schertenleib is also ranked by IAM Magazine ,as part of the top ten patent litigators in France.

“Denis Schertenleib is “prompt, pragmatic, creative, flexible, smart and reasonable. He is a fantastic adviser, always provides quick and effective counsel and has a great rapport with the court – it is obvious the judges respect his advocacy. He consistently delivers good results and is a go-to counsel”. He plies his trade at eponymous set-up Cabinet Schertenleib.”

 

IAM

 

 

 

 

 

Denis Schertenleib is also ranked by IAM Magazine ,as part of the top ten patent litigators in France.

“Denis Schertenleib is “prompt, pragmatic, creative, flexible, smart and reasonable. He is a fantastic adviser, always provides quick and effective counsel and has a great rapport with the court – it is obvious the judges respect his advocacy. He consistently delivers good results and is a go-to counsel”. He plies his trade at eponymous set-up Cabinet Schertenleib.”

 

9lWwzmQk_400x400

 

 

 

 

 

Cases handled by Cabinet Schertenleib in Litigation in the areas of generic drugs, biotechnology, telecoms or mechanics.

WWL